These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
102 related items for PubMed ID: 185642
1. Distribution of 35S-labeled WR-2721 in normal and malignant tissues of the mouse1,2. Utley JF, Marlowe C, Waddell WJ. Radiat Res; 1976 Nov; 68(2):284-91. PubMed ID: 185642 [No Abstract] [Full Text] [Related]
2. Biodistribution of the radioprotective drug 35S-labeled 3-amino-2-hydroxypropyl phosphorothioate (WR77913). Rasey JS, Grunbaum Z, Krohn KA, Menard TW, Spence AM. Radiat Res; 1985 Apr; 102(1):130-7. PubMed ID: 2984715 [Abstract] [Full Text] [Related]
3. Distribution of WR-2721 in normal and malignant tissues of mice and rats bearing solid tumors: dependence on tumor type, drug dose and species. Washburn LC, Carlton JE, Hayes RL. Radiat Res; 1974 Aug; 59(2):475-83. PubMed ID: 4371539 [No Abstract] [Full Text] [Related]
5. Comparison of the protective effects of three phosphorothioate radioprotectors in the RIF-1 tumor. Rasey JS, Krohn KA, Magee S, Nelson N, Chin L. Radiat Res; 1986 Nov; 108(2):167-75. PubMed ID: 3024202 [Abstract] [Full Text] [Related]
6. Pharmacokinetics of WR-1065 in mouse tissue following treatment with WR-2721. Utley JF, Seaver N, Newton GL, Fahey RC. Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1525-8. PubMed ID: 6090355 [Abstract] [Full Text] [Related]
7. Radioprotection of normal tissues against gamma rays and cyclotron neutrons with WR-2721: LD50 studies and 35S-WR-2721 biodistribution. Rasey JS, Nelson NJ, Mahler P, Anderson K, Krohn KA, Menard T. Radiat Res; 1984 Mar; 97(3):598-607. PubMed ID: 6328565 [Abstract] [Full Text] [Related]
8. [Studies on the radioprotective effects of YM-08310 (= WR-2721) Part 1: Radioprotective effects of YM-08310 on normal and malignant tissues in mice]. Tanaka Y, Akagi K, Hasegawa T, Nakazawa M, Harima K, Murata T, Sawada S. Nihon Igaku Hoshasen Gakkai Zasshi; 1983 May 25; 43(5):700-9. PubMed ID: 6312407 [No Abstract] [Full Text] [Related]
9. The role of WR-2721 in radiotherapy and/or chemotherapy. Yuhas JM, Spellman JM, Culo F. Cancer Clin Trials; 1980 May 25; 3(3):211-6. PubMed ID: 6254681 [Abstract] [Full Text] [Related]
12. Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino)-ethylphosphorothioic acid. Yuhas JM. Cancer Res; 1980 May 25; 40(5):1519-24. PubMed ID: 6245795 [Abstract] [Full Text] [Related]
17. Distribution of [3H]-3-hydroxykynurenine in mice. Watanabe M, Sugimori Y. Cancer Res; 1976 Feb 25; 36(2 Pt 1):309-12. PubMed ID: 1260739 [Abstract] [Full Text] [Related]
19. The distribution and metabolism of the radiation protective agent aminopentylaminoethylphosphorothioate in mice. Kollmann G, Martin D, Shapiro B. Radiat Res; 1971 Dec 25; 48(3):542-50. PubMed ID: 5137463 [No Abstract] [Full Text] [Related]
20. [Effect of pharmacological agents on the radioprotective activity, toxicity and distribution of 35S-labeled aminopropylaminoethyl-thiophosphate administered perorally]. Grechka II, Belavina LP, Kalistratov GV, Zherebchenko PG. Radiobiologiia; 1979 Dec 25; 19(3):372-6. PubMed ID: 223190 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]